Right now skin examination need cannot be served. Each dermatologist in Europe corresponds to 10K people. As malignancy rates increase practically no commercial system gives a robust scaling solution.
Current means are expensive, slow, bulky and not automated. More importantly, they don’t allow for other health care professionals to assist with the process.